Press Releases

ENPICOM Joins the Pistoia Alliance

ENPICOM today announced that it has joined the Pistoia Alliance, the global not-for-profit organization working to lower barriers to innovation in life science and healthcare R&D.

iProcess Global Research launches AxisOne: the R&D operating system for the world

iProcess Global Research Inc. today announced the launch of AxisOne, an AI-powered platform the company calls the R&D operating system for the world.

Leinco Technologies and CellCarta Collaborate to Advance Proteomics Solutions and Applications for Drug Development

Leinco Technologies and CellCarta are pleased to announce a strategic collaboration aimed at advancing proteomics solutions that will benefit the development of immuno-oncology and other targeted therapeutic modalities.

Autonomize AI introduces Version 3 of its Intelligence Platform, an AI operating layer for healthcare

Autonomize AI today announced Version 3 of its Autonomize Intelligence Platform, a complete foundation for building, deploying, and governing healthcare-native AI agents at enterprise scale.

Medix Biochemica appoints Petra Furu as Chief Executive Officer

The Board of Directors of Medix Biochemica appoints Petra Furu as Chief Executive Officer of the company, effective 1 June 2026.

Baylor Genetics to Showcase the Impact of Early Genome Sequencing at Annual PLUGS Summit

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be participating in the Patient-centered Laboratory Utilization Guidance Services (PLUGS) Summit in Seattle, WA from April 20-21, 2026. The company will also share data about the impact of early genome sequencing in patient care.

Aragen Launches ‘ChemiSHE’, India’s First Women-Led Chemistry Synthesis Laboratory

Aragen Launches ‘ChemiSHE’, India’s First Women-Led Chemistry Synthesis Laboratory

Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays

Biognosys Group today announced a major collaboration with The Michael J. Fox Foundation for Parkinson’s Research to advance the development of highly sensitive and quantitative biomarker assays for Parkinson’s disease.

Enhanced Compliance Inc. (ECI) Appoints Khalid Raja as Senior Vice President, Strategic Growth & Advisory

Enhanced Compliance Inc. today announced the appointment of Khalid Raja (Raj) as Senior Vice President, Strategic Growth & Advisory, effective April 13, 2026.

START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North Texas.

Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy

Certara Appoints Dr. Britta Wagenhuber as Head of Quantitative Systems Pharmacology (QSP) Consultancy

Plasmidsaurus Accelerates RNA-Seq: New EU Hub and Genovis Partnership Adds Stability to Speed, Without the Ice

Plasmidsaurus has announced two transformative evolutions of its RNA-Seq ecosystem.

eClinical Solutions elluminate® Platform Supports argenx to Enhance Data Oversight and Efficiency

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

Baylor Genetics Connects with Genetic Counselors to Advance Answers in Rare and Undiagnosed Disease

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will be participating in two upcoming genetic counselor conferences.

Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases

Abselion Appoints Dale Gordon as Chair

Bioprocessing leader to drive continued commercial development and international expansion

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

The team at ClearNote Health strengthened its leadership team with four key additions.

Babson Diagnostics Names Web Golinkin CEO

Babson Diagnostics has appointed Web Golinkin, formerly President and Chief Commercial Officer, as CEO and a member of the board to lead the company's next phase of commercial growth for its BetterWay™ blood testing system. Outgoing CEO David Stein, Ph.D., will transition to Executive Director to focus on strategic initiatives.